The ALPLA Group is acquiring Heinlein Plastik-Technik in an effort to expand its pharma division with closure systems, dosing systems, and application aids for pharmaceutical and medical products.

Heinlein’s 22,000m2 site utilizes injection moulding technologies and assembly machines to produce manufacture primary packaging made of plastic. Apparently, all the steps in its development, manufacturing, assembly, and delivery processes are subject to global quality assurance standards and certified in line with ISO 9001, HACCP, HMP 15378, and ISO 13485.

The company is reportedly ‘heavily involved in environmental matters and sustainability projects’ and intends to include its customers, partners, and suppliers in these efforts.

Although the contract between Heinlein and ALPLA was signed on 12th June 2024, the parties have agreed not to disclose the negotiated details of the transaction.

“I am delighted that we have been able to gain Heinlein Plastik-Technik, which is a long-established, global business,” says ALPLA CEO Philipp Lehner. “It is a good fit with our focus on the one hand on the dynamics of advancing technological innovations and on the global expansion of our business activities on the other.

“With the extensive know-how that Heinlein has to offer, we can expand our product portfolio to include high-quality primary packaging solutions for the pharma industry. The beneficiaries of this will first and foremost be our mutual customers, who will now be able to source their tailored system solutions from a single place.”

“With Heinlein Plastik-Technik at our side, our capacities in the area of injection moulding will now considerably increase once again,” adds Walter Knes, managing director of ALPLApharma. “We additionally plan to turn the Ansbach site into a technology centre for injection moulding and automation technology for the entire ALPLApharma group.”

Saskia Wellhöfer-Meyer, owner and CEO of Heinlein Plastik-Technik, concludes: “We look forward to applying our broad expertise in the development and production of precision closure and dosing systems. I firmly believe that, as we continue to operate largely independently as a “Member of ALPLApharma”, we will henceforth be in an even better position to cater to the market demand for comprehensive, high-quality and competitively priced system solutions.

In a similar business move, Syntegon has announced its plans to acquire Azbil Telstar and expand its liquid pharmaceutical processing and packaging portfolio with loading, unloading, and freeze-drying technologies.

Suzano also intends to purchase a 15% stake in Lenzing, a global producer of wood-based packaging materials, for €230 million. The partners have agreed on a long-term commitment to the existing Lenzing site which will ensure the company’s headquarters, production facilities and key R&D activities remain located in Austria.

If you liked this story, you might also enjoy:

How are the top brands progressing on packaging sustainability?

The ultimate guide to global plastic sustainability regulation

How bad is ‘greenwashing’ in fast fashion packaging?

A conversation with P&G’s Chief Sustainability Officer